These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9025847)

  • 1. Oxalate nephrocalcinosis: a study in autopsied infants and neonates.
    McCormick FC; Brady K; Keen CE
    Pediatr Pathol Lab Med; 1996; 16(3):479-88. PubMed ID: 9025847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tubular epithelium in the initiation and course of intratubular nephrocalcinosis.
    Vervaet BA; Verhulst A; De Broe ME; D'Haese PC
    Urol Res; 2010 Aug; 38(4):249-56. PubMed ID: 20680256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis.
    Marengo SR; Chen DH; Evan AP; Sommer AJ; Stowe NT; Ferguson DG; Resnick MI; MacLennan GT
    Urol Res; 2006 Jun; 34(3):200-10. PubMed ID: 16479391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis and hyperlipidemia in rats fed a cholesterol- and fat-rich diet: association with hyperoxaluria, altered kidney and bone minerals, and renal tissue phospholipid-calcium interaction.
    Schmiedl A; Schwille PO; Bonucci E; Erben RG; Grayczyk A; Sharma V
    Urol Res; 2000 Dec; 28(6):404-15. PubMed ID: 11221920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate nephrocalcinosis in renal tubular dysgenesis.
    Moldavsky M
    Pediatr Nephrol; 1999 Nov; 13(9):998-9. PubMed ID: 10671031
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants.
    Sikora P; Roth B; Kribs A; Michalk DV; Hesse A; Hoppe B
    Kidney Int; 2003 Jun; 63(6):2194-9. PubMed ID: 12753307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular and interstitial nephrocalcinosis.
    Kummeling MT; de Jong BW; Laffeber C; Kok DJ; Verhagen PC; van Leenders GJ; van Schaik RH; van Woerden CS; Verhulst A; Verkoelen CF
    J Urol; 2007 Sep; 178(3 Pt 1):1097-103. PubMed ID: 17644134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
    Sayer JA; Carr G; Simmons NL
    Clin Sci (Lond); 2004 Jun; 106(6):549-61. PubMed ID: 15027893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of calcium oxalate crystals in renal tubules.
    Khan SR; Hackett RL
    Scanning Microsc; 1991 Sep; 5(3):707-11; discussion 711-2. PubMed ID: 1808708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrocalcinosis in very low birth weight neonates: sonographic patterns, histologic characteristics, and clinical risk factors.
    Katz ME; Karlowicz MG; Adelman RD; Werner AL; Solhaug MJ
    J Ultrasound Med; 1994 Oct; 13(10):777-82. PubMed ID: 7823339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren.
    Patzer L; van't Hoff W; Shah V; Hallson P; Kasidas GP; Samuell C; de Bruyn R; Barratt TM; Dillon MJ
    J Pediatr; 1999 Nov; 135(5):611-7. PubMed ID: 10547250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and the development of nephrocalcinosis induced by injections of neutral phosphate in rats.
    Zalups RK
    Acta Morphol Hung; 1984; 32(2):121-5. PubMed ID: 6435400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in the kidneys and other organs; report of two cases.
    LUND T; RESKE-NIELSEN E
    Acta Pathol Microbiol Scand; 1956; 38(5):353-63. PubMed ID: 13339329
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.
    Steiger S; Grill JF; Ma Q; Bäuerle T; Jordan J; Smolle M; Böhland C; Lech M; Anders HJ
    Front Immunol; 2018; 9():619. PubMed ID: 29651290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiological case of the month. Infantile oxalosis: a rare cause of nephrocalcinosis].
    Mourani C; Torbey PH; Haddad-Zebouni S; Akkari V; Akatchérian C
    Arch Pediatr; 1999 Feb; 6(2):203-4. PubMed ID: 10079891
    [No Abstract]   [Full Text] [Related]  

  • 16. Lanthanum carbonate inhibits intestinal oxalate absorption and prevents nephrocalcinosis after oxalate loading in rats.
    Robijn S; Vervaet BA; Hoppe B; D'Haese PC; Verhulst A
    J Urol; 2013 May; 189(5):1960-6. PubMed ID: 23228382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic nephrocalcinosis in cystic fibrosis.
    Katz SM; Krueger LJ; Falkner B
    N Engl J Med; 1988 Aug; 319(5):263-6. PubMed ID: 3393180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrocalcinosis induced by hyperoxaluria in rats.
    Cunha NB; Kawano PR; Padovani CR; Lima Fde O; Bernardes S; Magalhães ES; Amaro CR; Amaro JL
    Acta Cir Bras; 2013 Jul; 28(7):496-501. PubMed ID: 23842930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.
    Marschner JA; Mulay SR; Steiger S; Anguiano L; Zhao Z; Boor P; Rahimi K; Inforzato A; Garlanda C; Mantovani A; Anders HJ
    Front Immunol; 2018; 9():2173. PubMed ID: 30319631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrocalcinosis and prematurity: importance of urate and oxalate excretion.
    Bérard E; Dageville C; Bekri S; Boutté P; Coussement A; Mariani R
    Nephron; 1995; 69(3):237-41. PubMed ID: 7753255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.